Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd
Case
•
[2015] FCA 848
•14 August 2015
Details
AGLC
Case
Decision Date
Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd [2015] FCA 848
[2015] FCA 848
14 August 2015
CaseChat Overview and Summary
In the case of Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd, the primary dispute arose from an interlocutory injunction granted by the primary judge to the appellants in a proceeding for patent infringement. The primary judge vacated this injunction upon finding that the relevant claims of the patent were invalid. The appellants sought a stay of the primary judge's order pending the determination of their appeal. The court had to decide whether to grant a stay and the appropriate terms for such a stay, including whether the Commonwealth should receive an undertaking as to damages specific to it and whether the appellants should provide security in relation to any claim by the Commonwealth.
The court considered the principles governing the application for a stay pending appeal, focusing on the strength of the appeal and the balance of convenience. The court found that the appeal had a reasonable prospect of success given the issues of patent validity. Additionally, the balance of convenience favoured the appellants, considering the respondent's intention to list generic products on the Pharmaceutical Benefits Scheme, which could significantly affect the market and the appellants' business. The court held that the Commonwealth, though not a party, should benefit from an undertaking as to damages specific to it, and that the appellants should provide security for such undertakings.
The court granted the stay and made several orders. The operation of certain orders made by Justice Yates was stayed until the appeal was determined. The respondent was required to withdraw any application it had made to list its products under the Pharmaceutical Benefits Scheme by a specified date. The appellants were ordered to provide additional security to the respondent and the Commonwealth in specified amounts by a set date. The court also prohibited the publication or disclosure of certain confidential annexures to affidavits filed in the appeal proceedings. Each party, including the Commonwealth, was granted liberty to apply for further orders. The costs of the interlocutory applications were reserved.
The court considered the principles governing the application for a stay pending appeal, focusing on the strength of the appeal and the balance of convenience. The court found that the appeal had a reasonable prospect of success given the issues of patent validity. Additionally, the balance of convenience favoured the appellants, considering the respondent's intention to list generic products on the Pharmaceutical Benefits Scheme, which could significantly affect the market and the appellants' business. The court held that the Commonwealth, though not a party, should benefit from an undertaking as to damages specific to it, and that the appellants should provide security for such undertakings.
The court granted the stay and made several orders. The operation of certain orders made by Justice Yates was stayed until the appeal was determined. The respondent was required to withdraw any application it had made to list its products under the Pharmaceutical Benefits Scheme by a specified date. The appellants were ordered to provide additional security to the respondent and the Commonwealth in specified amounts by a set date. The court also prohibited the publication or disclosure of certain confidential annexures to affidavits filed in the appeal proceedings. Each party, including the Commonwealth, was granted liberty to apply for further orders. The costs of the interlocutory applications were reserved.
Details
Key Legal Topics
Areas of Law
-
Civil Litigation & Procedure
-
Intellectual Property Law
Legal Concepts
-
Stay of Proceedings
-
Breach of Contract
-
Interlocutory Orders
-
Specific Performance
-
Compensatory Damages
Actions
Download as PDF
Download as Word Document
Most Recent Citation
Commissioner of State Revenue v McCabe (No 2) [2024] FCA 662
Cases Citing This Decision
10
High Court Bulletin
[2015] HCAB 7
Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 5)
[2024] FCA 1268
Commissioner of State Revenue v McCabe (No 2)
[2024] FCA 662
Cases Cited
5
Statutory Material Cited
4
Philip Morris (Australia) Ltd v Nixon
[1999] FCA 1281
Ekes v QBE Insurance (Australia) Limited
[2011] FCA 230
Kalifair Pty Ltd v Digi-Tech (Australia) Ltd
[2002] NSWCA 383